Thales-Exail: Agreement Finalized, Mandatory Bid at 134 € and Acquisition of Gorgé Family's 35.51% Stake
On July 30, 2026, Thales and Exail Technologies finalized their merger agreement, defined the terms of Thales's acquisition of the Gorgé family's stake (35.51% of capital) and clarified the timetable for the mandatory public offer at 134 € per share.
Agreement Signed Concerning the Acquisition of the Gorgé Stake
Thales and Exail Technologies have signed the merger agreement, the opening of negotiations for which was announced on July 6, 2026. This document sets out the terms of Thales's acquisition of all shares and ODIRNANE issued by Exail Technologies and not held by the Gorgé family, in the context of a mandatory public offer. The proposed price remains fixed at 134.00 € per share, in accordance with the initial announcement.
Implementation Timetable and Appointment of the Independent Expert
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The completion of the acquisition of the Gorgé family's stake, representing 35.51% of Exail Technologies' capital, is expected by the third quarter of 2027, subject to obtaining customary regulatory authorizations, particularly in matters of competition. The public offer for purchase covering 100% of the shares and ODIRNANE will subsequently be filed with the Financial Markets Authority, with completion expected by early 2028.
The board of directors of Exail Technologies has appointed the firm Ledouble, represented by Olivier Cretté and Romain Delafont, as independent expert. The board of directors, which welcomes this operation, will issue a reasoned opinion after examining the expert's fairness opinion.
croissance de +40% de son chiffre d'affaires au premier trimestre, excellente dynamique commerciale, trajectoire très favorable dans des marchés durablement porteurs
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
